Skip to main content

1 Result(s)

within Article Remove this filter Ming Chi Remove this filter Medicine & Public Health Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Targeted drug development in melanoma and nonsmall cell lung cancer: BRAF, MEK, and ALK inhibitors

    In the past few decades, many advances have been witnessed in the development of personalized molecular therapies, especially in the areas of melanoma and nonsmall cell lung cancer (NSCLC) among all other medi...

    Ming Chi… in memo - Magazine of European Medical Oncolo… (2012)